Microbot Medical Inc (MBOT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$1.440.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · MBOT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | — | — | — | — | — | 0.1 | — | 0.2 | 1.4 | 1.2 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | 0.1 | — | 0.2 | 1.4 | 1.2 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.1 | 1.0 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | 8.5 | — | — | — | — | — | — | — | — | — | — | 10.4 | 8.8 | 7.4 | 8.2 |
| R&D Expenses | 5.9 | 6.3 | 6.6 | 5.7 | 7.7 | 6.2 | 3.4 | 3.0 | 2.5 | 1.1 | (0.9) | (0.8) | 0.8 | 19.4 | 14.7 | 19.9 |
| Operating Income | (18.5) | (14.7) | (11.6) | (9.9) | (13.3) | (11.4) | (9.1) | (7.2) | (7.2) | 5.3 | (9.6) | 0.9 | (1.1) | (28.1) | (21.9) | (28.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.2 | 0.2 | 0.3 | 0.0 | 1.3 | 1.2 | 0.1 | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | (0.0) | 1.3 | 1.2 | 0.0 | 0.1 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | 0.3 | (1.4) | 2.1 | (6.1) | 6.7 |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | — | — | 36.4 | 32.7 | 26.4 | 28.5 | — |
| Income Tax Expense | — | — | — | — | — | — | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (16.3) | (13.1) | (11.4) | (10.7) | (13.2) | (11.3) | (9.2) | (7.2) | (7.3) | (7.6) | (9.7) | (0.9) | (1.2) | (26.4) | (28.5) | (21.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.24) | (0.29) | (0.73) | (1.05) | (1.81) | (1.59) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.24) | (0.29) | (0.73) | (1.05) | (1.81) | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 67.2 | 45.8 | 15.6 | 10.2 | 7.3 | 7.1 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 67.2 | 45.8 | 15.6 | 10.2 | 7.3 | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (14.7) | (11.5) | (9.7) | (13.2) | (11.3) | (9.0) | (7.2) | — | — | — | 2.0 | 0.2 | (27.0) | (20.9) | (26.9) |
| EBIT | (18.5) | (14.7) | (11.6) | (9.9) | (13.3) | (11.4) | (9.1) | (7.2) | (7.2) | 5.3 | (9.6) | 0.9 | (1.1) | (28.1) | (21.9) | (28.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.